GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 208 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2021. The put-call ratio across all filers is 0.56 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $30,461,000 | -25.6% | 953,396 | -19.4% | 6.97% | -28.0% |
| Q1 2022 | $40,955,000 | +88.3% | 1,182,307 | +59.1% | 9.68% | +35.1% |
| Q4 2021 | $21,748,000 | +241.4% | 743,000 | +197.2% | 7.17% | +209.6% |
| Q3 2021 | $6,370,000 | -13.4% | 250,000 | +19.0% | 2.32% | -23.4% |
| Q2 2021 | $7,354,000 | +3.1% | 210,000 | +20.0% | 3.02% | +0.6% |
| Q1 2021 | $7,131,000 | -23.4% | 175,000 | -18.6% | 3.01% | -9.7% |
| Q4 2020 | $9,312,000 | – | 215,000 | – | 3.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |